Literature DB >> 21915895

Neurologic indications for therapeutic plasma exchange: an update.

Kelly Gwathmey1, Rasheed A Balogun, Ted Burns.   

Abstract

Neurologists commonly use therapeutic plasma exchange (TPE, also known as plasmapheresis or therapeutic apheresis) to treat a number of conditions. This concise review examines the most common neurologic indications for therapeutic plasma exchange. It focuses on Guillain-Barrè syndrome and myasthenia gravis and also the role of TPE in chronic inflammatory demyelinating polyneuropathy, Lambert-Eaton syndrome, multiple sclerosis, neuromyelitis optica, paraproteinemic polyneuropathy, and Sydenham's chorea. As with any treatment, the proven efficacy, cost, side effects, and availability must be considered before initiation of therapy.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21915895     DOI: 10.1002/jca.20298

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  8 in total

Review 1.  Current topics in therapeutic plasmapheresis.

Authors:  Takeshi Nakanishi; Naoki Suzuki; Takahiro Kuragano; Yasuyuki Nagasawa; Yukiko Hasuike
Journal:  Clin Exp Nephrol       Date:  2013-07-26       Impact factor: 2.801

Review 2.  Update on neuromyelitis optica: natural history and management.

Authors:  Panitha Jindahra; T Plant
Journal:  Eye Brain       Date:  2012-03-26

3.  Mycobacterium W administration for steroid resistant optic neuritis with long-term follow-up.

Authors:  Aditya Sudhalkar; Mayuri Khamar; Bakulesh Khamar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-18       Impact factor: 3.117

4.  Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease.

Authors:  Ivana Nieto-Aristizábal; Álvaro J Vivas; Pablo Ruiz-Montaño; Cristian C Aragón; Iván Posso-Osorio; Jairo Quiñones; Julián Alejandro Rivillas; Gabriel J Tobón
Journal:  Autoimmune Dis       Date:  2020-07-31

5.  Remitting long-standing major depression in a multiple sclerosis patient with several concurrent conditions.

Authors:  Navzer D Sachinvala; Angeline Stergiou; Duane E Haines
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-04       Impact factor: 2.570

6.  Current options for the treatment of optic neuritis.

Authors:  John H Pula; Christopher J Macdonald
Journal:  Clin Ophthalmol       Date:  2012-07-31

Review 7.  Acute Transverse Myelitis in Children, Literature Review.

Authors:  Azita Tavasoli; Aidin Tabrizi
Journal:  Iran J Child Neurol       Date:  2018

Review 8.  Transverse myelitis.

Authors:  Shin C Beh; Benjamin M Greenberg; Teresa Frohman; Elliot M Frohman
Journal:  Neurol Clin       Date:  2013-02       Impact factor: 3.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.